BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38140044)

  • 1. Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein.
    Xu W; Xiao Y; Zheng L; Xu M; Jiang X; Wang L
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.
    Burande AS; Viswanadh MK; Jha A; Mehata AK; Shaik A; Agrawal N; Poddar S; Mahto SK; Muthu MS
    AAPS PharmSciTech; 2020 May; 21(5):151. PubMed ID: 32440910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells.
    Wang B; Li S; Meng X; Shang H; Guan Y
    Tumour Biol; 2015 Aug; 36(8):6433-43. PubMed ID: 25801244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors].
    Huang R; Yao X; Chen Y; Sun X; Lin Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):108-14. PubMed ID: 27382749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2.
    Wu ZL; Chen Y; Qu Z; Wu GY; He XF; Huang JW; Meng QQ; Hu YH; Shen XL; Yang RY; Hu YJ
    J Ethnopharmacol; 2022 Aug; 294():115353. PubMed ID: 35533911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X; Mo R; Ding Y; Zheng W; Zhang C
    Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel.
    Long J; Hu W; Ren T; Wang X; Lu C; Pan X; Wu C; Peng T
    Int J Pharm; 2024 Jan; 650():123718. PubMed ID: 38104849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells.
    Gao L; Liu G; Ma J; Wang X; Wang F; Wang H; Sun J
    Colloids Surf B Biointerfaces; 2014 May; 117():122-7. PubMed ID: 24632038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance.
    Wan CP; Letchford K; Jackson JK; Burt HM
    Int J Nanomedicine; 2013; 8():379-91. PubMed ID: 23378760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation.
    Wang Z; Yin J; Li M; Shen J; Xiao Z; Zhao Y; Huang C; Zhang H; Zhang Z; Cho CH; Wu X
    Chin Med; 2019; 14():7. PubMed ID: 30911326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study.
    Feng SL; Tian Y; Huo S; Qu B; Liu RM; Xu P; Li YZ; Xie Y
    Phytomedicine; 2020 Feb; 67():153141. PubMed ID: 31884406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
    Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
    Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethyleneimine- -Tocopherol Hydrogen Succinate/Hyaluronic Acid-Quercetin (PEI-TOS/HA-QU) Core-Shell Micelles Delivering Paclitaxel for Combinatorial Treatment of MDR Breast Cancer.
    Qian J; Liu S; Yang T; Xiao Y; Sun J; Zhao J; Zhang Z; Xie Y
    J Biomed Nanotechnol; 2021 Mar; 17(3):382-398. PubMed ID: 33875073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers.
    Yu J; Hu F; Zhu Q; Li X; Ren H; Fan S; Qian B; Zhai B; Yang D
    Nanoscale Res Lett; 2020 Mar; 15(1):59. PubMed ID: 32166458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.